CLOS
HAE icon

Compagnie Lombard Odier SCmA’s Haemonetics HAE Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,642
Closed -$442K – 929
2016
Q1 		$442K Buy
+12,642
New +$408K 0.01% 356

Other funds holding HAE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Compagnie Lombard Odier SCmA's HAE Position: Q2 2016 in Review

Compagnie Lombard Odier SCmA sold out of Haemonetics (HAE) in Q2 2016, closing a stake of 12,642 shares — an estimated $442K sold.

Compagnie Lombard Odier SCmA first reported a position in HAE in Q1 2016 and held it in 1 quarter. The position peaked at $442K in Q1 2016. 178 funds tracked by Wall St. Rank hold HAE as of Q2 2016.

  • Compagnie Lombard Odier SCmA reported no remaining Haemonetics position as of Q2 2016 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 12,642 Haemonetics shares in Q2 2016, an estimated $442K.
  • Compagnie Lombard Odier SCmA first reported a position in Haemonetics in Q1 2016 and held it in 1 quarter.
  • Compagnie Lombard Odier SCmA's Haemonetics position peaked at $442K in Q1 2016.
  • 178 funds tracked by Wall St. Rank held Haemonetics as of Q2 2016.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2016, filed 15 Aug 2016.